Search by Name - Presenter / Author
Kylie co-founded Little Stroke Warriors with fellow mother and advocate Dee Banks in 2016. Since the inception of Little Stroke Warriors, Kylie has been actively involved in advocating for education, awareness and funding for research into Childhood and Neonatal Stroke. A major achievement has been the development of the My Family Stroke Journey resource in collaboration with the Stroke Foundation and the awarding of the “Improving Life After Stroke” award in the 2018 Stroke Foundation awards. Outside of Kylie’s work with Little Stroke Warriors and the Stroke Foundation, she is actively involved in advocating for children with Cerebral Palsy via liaisons with the Cerebral Palsy Alliance and has provided consumer consultation services to the NSW Paediatric Rehabilitation Service working group on Telehealth. Kylie is mother to 5 year old Anika who suffered a stroke in-utero.
Auckland University of Technology
National Institute for Stroke and Applied Neurosciences
Professor Feigin is Professor of Neurology and Epidemiology and the Director of the National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, New Zealand, and Affiliate Professor of the University of Washington, USA. He is also Honorary Professor of the Novosibirsk State Medical University, Russia, a Visiting Professor of the Capital Medical University of China, a Fellow of the Royal Society of New Zealand, American Academy of Neurology, and Russian Academy of Sciences. Professor Feigin’s prime research interest is in the epidemiology, prevention and management of stroke, dementia and traumatic brain injury. He published over 420 journal articles, totalling over 200,000 citations. Valery Feigin is one of the 1% most cited scientists worldwide (Web of Science h-index in June 2021 was 91). ). Just from the last year (2020) to 2021 his citation rate is one every 15 minutes, and rising.
Eberhard Karl University of Tuebingen
Neurology & Stroke
Since November 2021, I am working as a senior physician at the University Hospital Tübingen (UKT), Department of Neurology & Stroke. I am responsible for the stroke unit, IMC, ICU and the emergency department. I did my residency starting in February 2011 in the university hospital of Munich (LMU) and completed my training in February 2019. During my training, I was primarily employed in neurological acute and intensive care. From December 2019 until October 2020, I was working in telemedicine for the Neurovascular Network of Southwest Bavaria (NEVAS). Scientifically, I first worked in the research group of Prof. Dr. M. Strupp on dizziness and balance disorders, especially vestibular and cerebellar disorders and their treatment options. I completed my habilitation in neurology on the topic "Improvement of the diagnosis of vertigo syndromes and therapy of cerebellar vertigo disorders" in March 2020. In the context of this scientific occupation, I raised a BMBF grant of 1,044,865 EUR for the now completed, multicenter, international ALCAT study (grant number: 01KG1422). However, as my clinical focus was - as mentioned above - mainly in acute/emergency and intensive care medicine, I decided to establish an additional scientific focus in vascular medicine (working group of Prof. Dr. L. Kellert). In the meantime, I have also published very successfully in this field, regarding the acute treatment options in stroke including intravenous thrombolysis, mechanical thrombectomy and clinical factors for success and outcome. Further funding I have obtained was in the context of a - currently ongoing - monocentric study on the efficacy of ipad-based speech therapy after stroke ("Lexi Study", funding amount 10.000 € by Boehringer Ingelheim).
Hospital de Santa Maria, CHULN; Universidade de Lisboa
Department of Neurosciences (Neurology)
José M. Ferro was born in Lisbon, Portugal, on the 22nd October 1951. He graduated in 1975 and received his PhD in Medicine in 1987 from the the University of Lisbon. He was a post-doctoral fellow at the Department of Clinical Neurological Sciences, London, Canada. He is currently Full Professor of Neurology at the Faculdade de Medicina, Universidade de Lisboa, and Director of the Department of Neurosciences and Mental Health and of the Neurology Service at the Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, EPE. He is Principal Investigator at the Instituto de Medicina Molecular João Lobo Antunes, University of Lisbon. He was President of the European Neurological Society, Chairman of the Stroke Portuguese Society and member of the Scientific Panel for Health of the Directorate-General for Research and Innovation, Directorate E – Health of the European Commission. Has authored or co-authored 360 papers published in peer-reviewed journals and 60 book chapters. His research interest focuses on cerebrovascular disease, in particular cerebral venous thrombosis, cryptogenic stroke, stroke in systemic diseases and neuropsychiatric consequences of stroke.
Boehringer INgelheim International GmbH
Thomas Fischer Boehringer Ingelheim International GmbH Healthcare Affairs & Patient Engagement Global Teamleader and Co-founder of the Angels Initiative Tel.: +49 (6132) 77-2251 mailto:email@example.com Thomas was born in Mannheim, Germany, in 1957. After finishing school, he studied Mathematics and Biology at University Karlsruhe. Upon completing his degree, he went on to teach for two years in several high schools in Germany. In 1985, Thomas joined the Boehringer Ingelheim team in different positions in Sales, Training and Marketing in Germany in the therapeutic areas Cardiovascular and HIV. In 2004, Thomas joined the Corporate Management team in a couple of diseases as HIV, Parkinson’s disease, myocardial infarction and stroke. Getting more and more involved in stroke care projects like QUICK, Arabic Health and ESO EAST, Thomas developed together with Jan the concept of the Angels Initiative. Because of the non-commercial character of the Angels Initiative it moved within the company first to the Medical division and this year to Health Care Affairs & Patient Engagement. Since the launch of the Angels Initiative 5 years ago it developed to a community of more than 61.000 healthcare professionals from 5.500 hospitals in 130 countries. Just recently the Angels Initiative has been showcased as “best practice” example for capacity building in Low and Middle Income Countries in the Report Access to Medicine Index Report.
Beth Israel Deaconess Medical Center
Dr. Fisher has had a long career as a translational and clinical researcher in the stroke field. He was at the University of Massachusetts Medical School for 36 years, retiring in 2014. While there, he led a stroke modeling lab for 25 years that focused on using MRI technology to evaluate the ischemic penumbra and the effects of many types of therapies on the evolution of ischemic injury. He trained more than 25 research fellows from around the world, many of whom currently hold prestigious positions. He participated in many clinical trials as a principal investigator or steering committee member. Dr. Fisher was also an active clinician and teacher. He has published more than 330 peer reviewed papers with an h-index of 80. Currently, Dr. Fisher is a part time member of the neurology faculty at Beth Israel Deaconess Medical Center in Boston and is a Professor of Neurology (part time) at Harvard Medical School. He continues to see patients and teach residents and stroke fellows. He was the Editor will -in-Chief of Stroke from 2010-2020 and continues to serve Stroke as a senior consulting editor. He assumed the presidency of the WSO in November 2020.
Hospital de Santa Maria
Ana Catarina Fonseca is a neurology consultant and has a PhD in Medicine, from the Faculty of Medicine, University of Lisbon (2014). In 2014, she completed a Masters in Public Health from Harvard University (USA), having previously completed two masters: in Stroke Medicine at the University Danube Krems (Austria) and in Neuroscience at the University of Lisbon. She is a researcher at the Instituto de Medicina Molecular where she manages the stroke biobank collection, teaches Pharmacology and Neurology at the Faculty of Medicine (University of Lisbon) and works at the stroke unit of Hospital de Santa Maria in Lisbon, Portugal. She participated in the “value of treatment project” of the European Brain Council” and in the writing of guidelines for the “European Stroke Organization”. She is an editorial board member for Stroke and BMC Neurology. Her main research interests are cryptogenic stroke, heart-brain interactions and precision medicine.
University of Texas McGovern Medical School
I am a pediatric stroke neurologist, having completed both a child neurology residency and ACGME-eligible vascular neurology fellowship. I am the director of the UTHealth Pediatric Stroke Program in partnership with the departments of pediatrics and the UTHealth Stroke Institute. I'm most interested in improving recovery for children after stroke.